Position in MRVI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,954,952
+$63,573 QoQ
Shares Held
1,595,345
-54.4% QoQ
Ownership
0.614%
of shares outstanding
% of Portfolio
4.10%
of 13F equity value
Holder Rank
#28
of 177 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tejara Capital Ltd holds $21,229,968 across 5 Biotechnology names. MRVI ranks #1 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
This page
|
1,595,345 | $9,954,952 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
607,039 | $4,862,382 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
113,084 | $2,965,062 | |
| 4 | HRTX |
Heron Therapeutics, Inc. /De/
|
6,510,795 | $2,799,641 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
2,037,520 | $647,931 |
All Filings in MRVI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,954,952 | 1,595,345 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,891,379 | 3,495,187 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,815,679 | 3,020,209 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,041,375 | 2,453,441 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,678,892 | 1,941,449 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,199,033 | 542,549 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||